The elastomeric infusion pumps market is poised to grow from USD 1.15 billion in 2025 to USD 1.49 billion by 2030, at a CAGR of 5.3%. Increasing demand in oncology, pain management, anesthesia, and ...

The Infusion Pump Market represents a critical segment within modern healthcare technology, enabling controlled and accurate ...

The FDA has expanded the indication for Fiasp (insulin aspart injection; Novo Nordisk) 100 Units/mL to include use in insulin infusion pumps to improve glycemic control in adults with type 1 or type 2 ...

Despite increasing chemoradiotherapy treatment, there is a paucity of information regarding the effects of radiation exposure on ambulatory infusion pumps used to deliver chemotherapy or other ...

The Diabetes Control and Complications Trial research group documented that low glycosylated hemoglobin (HbA1c) levels were associated with reduced onset and progression of microvascular complications ...

Hospitals should pay particularly close attention to potential errors related to large-volume infusion pumps, an influential device-testing company has advised. ECRI Institute of Plymouth Meeting, ...

Data suggest machine learning and artificial intelligence could help hospitals align drug libraries more closely to clinical practices, which may advance infusion safety Study conducted in partnership ...

After multiple issues and more than 3,500 complaints logged over four years, InfuTronix is pulling some 52,000 of its Nimbus II infusion pump systems from the market and opting for a complete redesign ...

On April 30, FDA sent a letter to Baxter Healthcare Corp. ordering the company to recall and destroy all of its Colleague Volumetric infusion pumps currently in use in the United States. This action, ...

You've probably seen an infusion pump, even though the name might make it sound like a mysterious piece of medical technology. These devices govern the flow of IV medications and fluids into patients.